Goldman Sachs’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-612,388
| Closed | -$48.9M | – | 6800 |
|
|
2021
Q1 | $48.9M | Buy |
612,388
+437,180
| +250% | +$34.1M | 0.01% | 1180 |
|
|
2020
Q4 | $13.8M | Sell |
175,208
-45,412
| -21% | -$2.66M | ﹤0.01% | 2184 |
|
|
2020
Q3 | $9.69M | Sell |
220,620
-548,989
| -71% | -$27M | ﹤0.01% | 2356 |
|
|
2020
Q2 | $34M | Buy |
769,609
+466,236
| +154% | +$17.4M | 0.01% | 1260 |
|
|
2020
Q1 | $10.9M | Buy |
303,373
+102,557
| +51% | +$5.83M | ﹤0.01% | 2031 |
|
|
2019
Q4 | $14.2M | Sell |
200,816
-59,663
| -23% | -$4.33M | ﹤0.01% | 2151 |
|
|
2019
Q3 | $19.5M | Sell |
260,479
-28,321
| -10% | -$2.4M | 0.01% | 1803 |
|
|
2019
Q2 | $23.3M | Buy |
288,800
+139,676
| +94% | +$9.82M | 0.01% | 1730 |
|
|
2019
Q1 | $9.97M | Sell |
149,124
-10,817
| -7% | -$819K | ﹤0.01% | 2422 |
|
|
2018
Q4 | $11.9M | Sell |
159,941
-27,539
| -15% | -$2.27M | ﹤0.01% | 2214 |
|
|
2018
Q3 | $17.3M | Sell |
187,480
-71,614
| -28% | -$6.82M | ﹤0.01% | 2027 |
|
|
2018
Q2 | $25.5M | Buy |
259,094
+57,712
| +29% | +$6.45M | 0.01% | 1707 |
|
|
2018
Q1 | $22.4M | Buy |
201,382
+46,649
| +30% | +$5.23M | 0.01% | 1768 |
|
|
2017
Q4 | $15.9M | Sell |
154,733
-86,728
| -36% | -$8.64M | ﹤0.01% | 2121 |
|
|
2017
Q3 | $22.7M | Buy |
241,461
+163,468
| +210% | +$12.9M | 0.01% | 1875 |
|
|
2017
Q2 | $6.08M | Sell |
77,993
-11,765
| -13% | -$884K | ﹤0.01% | 2902 |
|
|
2017
Q1 | $7.19M | Sell |
89,758
-26,160
| -23% | -$2.08M | ﹤0.01% | 2638 |
|
|
2016
Q4 | $9.13M | Sell |
115,918
-114,681
| -50% | -$8.91M | ﹤0.01% | 2538 |
|
|
2016
Q3 | $18M | Buy |
230,599
+86,409
| +60% | +$6.27M | 0.01% | 1970 |
|
|
2016
Q2 | $9.91M | Buy |
144,190
+54,665
| +61% | +$3.77M | ﹤0.01% | 2330 |
|
|
2016
Q1 | $6.39M | Sell |
89,525
-7,714
| -8% | -$484K | ﹤0.01% | 2555 |
|
|
2015
Q4 | $6.04M | Buy |
97,239
+2,767
| +3% | +$169K | ﹤0.01% | 2661 |
|
|
2015
Q3 | $5.36M | Sell |
94,472
-11,452
| -11% | -$606K | ﹤0.01% | 2825 |
|
|
2015
Q2 | $5.68M | Sell |
105,924
-31,556
| -23% | -$1.53M | ﹤0.01% | 2856 |
|
|
2015
Q1 | $6.53M | Buy |
137,480
+32,690
| +31% | +$1.45M | ﹤0.01% | 2656 |
|
|
2014
Q4 | $4.53M | Buy |
104,790
+33,406
| +47% | +$1.36M | ﹤0.01% | 3093 |
|
|
2014
Q3 | $2.46M | Buy |
71,384
+29,286
| +70% | +$1.03M | ﹤0.01% | 3734 |
|
|
2014
Q2 | $1.54M | Sell |
42,098
-6,319
| -13% | -$214K | ﹤0.01% | 4268 |
|
|
2014
Q1 | $1.63M | Sell |
48,417
-33,508
| -41% | -$1.11M | ﹤0.01% | 4159 |
|
|
2013
Q4 | $2.78M | Buy |
81,925
+258
| +0.3% | +$8.94K | ﹤0.01% | 3731 |
|
|
2013
Q3 | $2.6M | Sell |
81,667
-10,285
| -11% | -$274K | ﹤0.01% | 3666 |
|
|
2013
Q2 | $2.08M | Buy |
+91,952
| New | +$1.99M | ﹤0.01% | 3688 |
|
Goldman Sachs's CMD Position: Q2 2021 in Review
Goldman Sachs sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 612,388 shares — an estimated $48.9M sold.
Goldman Sachs first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $48.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Goldman Sachs reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Goldman Sachs sold 612,388 Cantel Medical Corporation shares in Q2 2021, an estimated $48.9M.
- Goldman Sachs first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Goldman Sachs's Cantel Medical Corporation position peaked at $48.9M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.